Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Matthew G. Gartland is active.

Publication


Featured researches published by Matthew G. Gartland.


AIDS | 2013

Field effectiveness of combination antiretroviral prophylaxis for the prevention of mother-to-child HIV transmission in rural Zambia

Matthew G. Gartland; Namwinga Chintu; Michelle S. Li; Mwila K. Lembalemba; Saziso N. Mulenga; Maximillian Bweupe; Patrick Musonda; Elizabeth M. Stringer; Jeffrey S. A. Stringer; Benjamin H. Chi

Objective:To evaluate the effectiveness of maternal combination antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV (PMTCT) in a program setting. Design:Prospective cohort study. Setting:Nine primary care clinics in rural Zambia. Participants:Two hundred and eighty-four HIV-infected pregnant women at at least 28 weeks gestation initiating PMTCT services between April 2009 and January 2011 and their newborn infants. Intervention:In four ‘intervention’ sites, PMTCT comprised universal combination antiretroviral prophylaxis (i.e. irrespective of CD4 cell count) from pregnancy until the cessation of breastfeeding. In five ‘control’ sites, women received antenatal zidovudine and peripartum nevirapine, the standard of care at the time. Prophylaxis during breastfeeding was not available in control sites. Main outcome measure:Cumulative infant HIV infection and death at 12 months postpartum. Results:At 12 month postpartum, one of 104 (1.0%) infants born to mothers at the intervention sites were HIV-infected, compared with 14 of 116 (12.1%) receiving care in the control sites [relative risk (RR): 12.6, 95% CI: 2.2–73.1; P = 0.005]. When we considered the composite outcome of HIV infection or death, similar trends were observed in the overall study population (RR: 3.4, 95% CI: 1.6–7.6; P = 0.002) and in a sub-analysis of women with CD4 cell count more than 350 cells/&mgr;l (RR: 3.2; 95% CI: 1.1–9.6; P = 0.04). Conclusion:When compared with PMTCT services based on antenatal zidovudine and peripartum nevirapine, the provision of maternal combination prophylaxis imparted measurable health benefits to HIV-exposed infants. Implementation research is needed to further tailor and optimize these strategies for similar field settings.


Journal of Acquired Immune Deficiency Syndromes | 2015

Implementation and Operational Research: Distance From Household to Clinic and Its Association With the Uptake of Prevention of Mother-to-Child HIV Transmission Regimens in Rural Zambia.

Escamilla; Carla J. Chibwesha; Matthew G. Gartland; Namwinga Chintu; Mwangelwa Mubiana-Mbewe; Musokotwane K; Patrick Musonda; William C. Miller; Jeffrey S. A. Stringer; Benjamin H. Chi

Background:In rural settings, HIV-infected pregnant women often live significant distances from facilities that provide prevention of mother-to-child transmission (PMTCT) services. Methods:We offered universal maternal combination antiretroviral regimens in 4 pilot sites in rural Zambia. To evaluate the impact of services, we conducted a household survey in communities surrounding each facility. We collected information about HIV status and antenatal service utilization from women who delivered in the past 2 years. Using household Global Positioning System coordinates collected in the survey, we measured Euclidean (i.e., straight line) distance between individual households and clinics. Multivariable logistic regression and predicted probabilities were used to determine associations between distance and uptake of PMTCT regimens. Results:From March to December 2011, 390 HIV-infected mothers were surveyed across four communities. Of these, 254 (65%) had household geographical coordinates documented. One hundred sixty-eight women reported use of a PMTCT regimen during pregnancy including 102 who initiated a combination antiretroviral regimen. The probability of PMTCT regimen initiation was the highest within 1.9 km of the facility and gradually declined. Overall, 103 of 145 (71%) who lived within 1.9 km of the facility initiated PMTCT versus 65 of 109 (60%) who lived farther away. For every kilometer increase, the association with PMTCT regimen uptake (adjusted odds ratio: 0.90, 95% confidence interval: 0.82 to 0.99) and combination antiretroviral regimen uptake (adjusted odds ratio: 0.88, 95% confidence interval: 0.80 to 0.97) decreased. Conclusions:In this rural African setting, uptake of PMTCT regimens was influenced by distance to health facility. Program models that further decentralize care into remote communities are urgently needed.


Bulletin of The World Health Organization | 2014

Universal combination antiretroviral regimens to prevent mother-to-child transmission of HIV in rural Zambia: a two-round cross-sectional study

Benjamin H. Chi; Patrick Musonda; Mwila K. Lembalemba; Namwinga Chintu; Matthew G. Gartland; Saziso N. Mulenga; Maximillian Bweupe; Eleanor Turnbull; Elizabeth M. Stringer; Jeffrey S. A. Stringer

OBJECTIVE To evaluate if a pilot programme to prevent mother-to-child transmission (PMTCT) of the human immunodeficiency virus (HIV) was associated with changes in early childhood survival at the population level in rural Zambia. METHODS Combination antiretroviral regimens were offered to pregnant and breastfeeding, HIV-infected women, irrespective of immunological status, at four rural health facilities. Twenty-four-month HIV-free survival among children born to HIV-infected mothers was determined before and after PMTCT programme implementation using community surveys. Households were randomly selected and women who had given birth in the previous 24 months were asked to participate. Mothers were tested for HIV antibodies and children born to HIV-infected mothers were tested for viral deoxyribonucleic acid. Multivariable models were used to determine factors associated with child HIV infection or death. FINDINGS In the first survey (2008-2009), 335 of 1778 women (18.8%) tested positive for HIV. In the second (2011), 390 of 2386 (16.3%) tested positive. The 24-month HIV-free survival in HIV-exposed children was 0.66 (95% confidence interval, CI: 0.63-0.76) in the first survey and 0.89 (95% CI: 0.83-0.94) in the second. Combination antiretroviral regimen use was associated with a lower risk of HIV infection or death in children (adjusted hazard ratio: 0.33, 95% CI: 0.15-0.73). Maternal knowledge of HIV status, use of HIV tests and use of combination regimens during pregnancy increased between the surveys. CONCLUSION The PMTCT programme was associated with an increased HIV-free survival in children born to HIV-infected mothers. Maternal utilization of HIV testing and treatment in the community also increased.


BMJ Open | 2012

Access to facility delivery and caesarean section in north-central Liberia: a cross-sectional community-based study

Matthew G. Gartland; Victor Taryor; Andy M. Norman; Sten H. Vermund

Objective Rural north-central Liberia has one of the worlds highest maternal mortality ratios. We studied health facility birthing service utilisation and the motives of women seeking or not seeking facility-based care in north-central Liberia. Design Cross-sectional community-based structured interviews and health facility medical record review. Setting A regional hospital and the surrounding communities in rural north-central Liberia. Participants A convenience sample of 307 women between 15 and 49 years participated in structured interviews. 1031 deliveries performed in the regional hospital were included in the record review. Primary outcomes Delivery within a health facility and caesarean delivery rates were used as indicators of direct utilisation of care and as markers of availability of maternal health services. Results Of 280 interview respondents with a prior childbirth, only 47 (16.8%) delivered their last child in a health facility. Women who did not use formal services cited cost, sudden labour and family tradition or religion as their principal reasons for home delivery. At the regional hospital, the caesarean delivery rate was 35.5%. Conclusions There is an enormous unmet need for maternal health services in north-central Liberia. Greater outreach and referral services as well as community-based education among women, family members and traditional midwives are vital to improve the timely utilisation of care.


American Journal of Tropical Medicine and Hygiene | 2014

Global Health Research in Narrative: A Qualitative Look at the FICRS-F Experience

Benjamin Bearnot; Alexandra Coria; Brian Scott Barnett; Eva H. Clark; Matthew G. Gartland; Devan Jaganath; Emily Mendenhall; Lillian Seu; Ayaba G. Worjoloh; Catherine Lem Carothers; Sten H. Vermund; Douglas C. Heimburger

For American professional and graduate health sciences trainees, a mentored fellowship in a low- or middle-income country (LMIC) can be a transformative experience of personal growth and scientific discovery. We invited 86 American trainees in the Fogarty International Clinical Research Scholars and Fellows Program and Fulbright-Fogarty Fellowship 2011-2012 cohorts to contribute personal essays about formative experiences from their fellowships. Nine trainees contributed essays that were analyzed using an inductive approach. The most frequently addressed themes were the strong continuity of research and infrastructure at Fogarty fellowship sites, the time-limited nature of this international fellowship experience, and the ways in which this fellowship period was important for shaping future career planning. Trainees also addressed interaction with host communities vis-à-vis engagement in project implementation. These qualitative essays have contributed insights on how a 1-year mentored LMIC-based research training experience can influence professional development, complementing conventional evaluations. Full text of the essays is available at http://fogartyscholars.org/.


Journal of Acquired Immune Deficiency Syndromes | 2013

Predictors of patient attrition according to different definitions for loss to follow-up:a comparative analysis from Lusaka, Zambia

Michelle S. Li; Patrick Musonda; Matthew G. Gartland; Priscilla L. Mulenga; Albert Mwango; Jeffrey S. A. Stringer; Benjamin H. Chi

Patient retention is critical to the long-term success of antiretroviral therapy (ART) programs worldwide. Continued follow-up in HIV care is important to ensure drug adherence, to evaluate the emergence of toxicities, to monitor treatment response, and to provide entry into other healthcare services.1 However, many have reported substantial losses to follow-up (LTFU) longitudinally. A systematic review of 39 cohorts in sub-Saharan Africa estimated program attrition (deaths and LTFU) to be 22.6% at 12 months, 25.0% at 24 months, and 29.5% at 36 months.2


Bulletin of The World Health Organization | 2014

Tratamientos antirretrovirales de combinación universal para prevenir la transmisión maternoinfantil del VIH en las zonas rurales de Zambia: un estudio transversal de dos vueltas

Benjamin H. Chi; Patrick Musonda; Mwila K. Lembalemba; Namwinga Chintu; Matthew G. Gartland; Saziso N. Mulenga; Maximillian Bweupe; Eleanor Turnbull; Elizabeth M. Stringer; Jeffrey S. A. Stringer

OBJECTIVE To evaluate if a pilot programme to prevent mother-to-child transmission (PMTCT) of the human immunodeficiency virus (HIV) was associated with changes in early childhood survival at the population level in rural Zambia. METHODS Combination antiretroviral regimens were offered to pregnant and breastfeeding, HIV-infected women, irrespective of immunological status, at four rural health facilities. Twenty-four-month HIV-free survival among children born to HIV-infected mothers was determined before and after PMTCT programme implementation using community surveys. Households were randomly selected and women who had given birth in the previous 24 months were asked to participate. Mothers were tested for HIV antibodies and children born to HIV-infected mothers were tested for viral deoxyribonucleic acid. Multivariable models were used to determine factors associated with child HIV infection or death. FINDINGS In the first survey (2008-2009), 335 of 1778 women (18.8%) tested positive for HIV. In the second (2011), 390 of 2386 (16.3%) tested positive. The 24-month HIV-free survival in HIV-exposed children was 0.66 (95% confidence interval, CI: 0.63-0.76) in the first survey and 0.89 (95% CI: 0.83-0.94) in the second. Combination antiretroviral regimen use was associated with a lower risk of HIV infection or death in children (adjusted hazard ratio: 0.33, 95% CI: 0.15-0.73). Maternal knowledge of HIV status, use of HIV tests and use of combination regimens during pregnancy increased between the surveys. CONCLUSION The PMTCT programme was associated with an increased HIV-free survival in children born to HIV-infected mothers. Maternal utilization of HIV testing and treatment in the community also increased.


Bulletin of The World Health Organization | 2014

Thérapies antirétrovirales combinées universelles pour prévenir la transmission mère-enfant du VIH en Zambie rurale: Une étude transversale en deux tours

Benjamin H. Chi; Patrick Musonda; Mwila K. Lembalemba; Namwinga Chintu; Matthew G. Gartland; Saziso N. Mulenga; Maximillian Bweupe; Eleanor Turnbull; Elizabeth M. Stringer; Jeffrey S. A. Stringer

OBJECTIVE To evaluate if a pilot programme to prevent mother-to-child transmission (PMTCT) of the human immunodeficiency virus (HIV) was associated with changes in early childhood survival at the population level in rural Zambia. METHODS Combination antiretroviral regimens were offered to pregnant and breastfeeding, HIV-infected women, irrespective of immunological status, at four rural health facilities. Twenty-four-month HIV-free survival among children born to HIV-infected mothers was determined before and after PMTCT programme implementation using community surveys. Households were randomly selected and women who had given birth in the previous 24 months were asked to participate. Mothers were tested for HIV antibodies and children born to HIV-infected mothers were tested for viral deoxyribonucleic acid. Multivariable models were used to determine factors associated with child HIV infection or death. FINDINGS In the first survey (2008-2009), 335 of 1778 women (18.8%) tested positive for HIV. In the second (2011), 390 of 2386 (16.3%) tested positive. The 24-month HIV-free survival in HIV-exposed children was 0.66 (95% confidence interval, CI: 0.63-0.76) in the first survey and 0.89 (95% CI: 0.83-0.94) in the second. Combination antiretroviral regimen use was associated with a lower risk of HIV infection or death in children (adjusted hazard ratio: 0.33, 95% CI: 0.15-0.73). Maternal knowledge of HIV status, use of HIV tests and use of combination regimens during pregnancy increased between the surveys. CONCLUSION The PMTCT programme was associated with an increased HIV-free survival in children born to HIV-infected mothers. Maternal utilization of HIV testing and treatment in the community also increased.


Antiviral Therapy | 2001

AVANTI 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients.

Matthew G. Gartland


Antiviral Therapy | 1999

AVANTI 1: randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus loviride in HIV-infected antiretroviral-naive patients. AVANTI Study Group.

Gatell J; Lange J; Matthew G. Gartland

Collaboration


Dive into the Matthew G. Gartland's collaboration.

Top Co-Authors

Avatar

Jeffrey S. A. Stringer

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Namwinga Chintu

Centre for Infectious Disease Research in Zambia

View shared research outputs
Top Co-Authors

Avatar

Elizabeth M. Stringer

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Benjamin H. Chi

Centre for Infectious Disease Research in Zambia

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Saziso N. Mulenga

Centre for Infectious Disease Research in Zambia

View shared research outputs
Top Co-Authors

Avatar

Eleanor Turnbull

Centre for Infectious Disease Research in Zambia

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge